Observational study / 2015
Higher urinary arsenic concentrations were associated with increased odds of being seronegative for varicella zoster virus IgG in US individuals.
Researchers analyzed cross-sectional data from 3,348 participants aged 6-49 years from the 2003-2004 and 2009-2010 NHANES cycles to evaluate urinary arsenic and VZV IgG seroprevalence. The overall weighted seronegative prevalence of VZV was 2.2%. After adjusting for covariates, odds ratios for a negative VZV IgG result per 1-unit increase in ln-TUA1 and ln-TUA2 were 1.87 (95% CI: 1.03, 3.44) and 1.40 (95% CI: 1.0, 1.97), respectively. The authors concluded that urinary arsenic was inversely associated with VZV IgG seroprevalence.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional study
- Who was studied
- 3,348 NHANES participants (2003-2004 and 2009-2010 cycles) aged 6-49 years
- What was measured
- Seroprevalence of varicella zoster virus (VZV) IgG antibody in relation to urinary arsenic concentrations
THE PAPER
Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010).
Cardenas A, Smit E, Houseman EA, Kerkvliet NI, Bethel JW, Kile ML. Environ Health Perspect, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.